Home » Topics » BioWorld Science

BioWorld Science
RSS

Vion Pharmaceuticals expands pivotal trials of new cancer treatment

Nov. 21, 1996

Antimalarial combination demonstrates excellent efficacy

Nov. 21, 1996

Company Profile: Inex

Nov. 21, 1996

Genetics Institute's factor IX scheduled for review

Nov. 21, 1996

Company Profile: Megabios

Nov. 21, 1996

Approval recommended for Elan's gel formulation of diazepam

Nov. 21, 1996

Taxotere approved in three additional markets

Nov. 21, 1996

First regulatory approval for impotence treatment

Nov. 21, 1996

First filing for Imutec's Virulizin

Nov. 21, 1996

SIBIA Neurosciences reports preclinical results with NAChR-selective compounds

Nov. 21, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...